IVF Research Study Georgia Reproductive Specialists is currently recruiting women experiencing infertility to take part in a clinical research study. The purpose of the study is to evaluate a new medication in women undergoing In Vitro Fertilization (IVF). The participants must be non-smokers between the ages of 18 and 34, with two functioning ovaries and a Body Mass Index of 34 or below. Additional screening will be conducted to determine if a patient is eligible to participate. Women who qualify and undergo an IVF treatment cycle will receive investigational medications at no cost to them and a significant reduction in IVF fees. Ovulation induction medications will be available at a discount. Individuals interested in participating are invited to call 404-591-1373. Reproductive Specialists applies medical science's most advanced fertility technologies to provide the highest standards of patient-centered, reproductive healthcare. The staff at GRS, including infertility laboratory pioneer Michael Tucker, Ph.D., focuses on providing individualized, innovative solutions for reproductive challenges and infertility, specializing in in vitro fertilization, intracytoplasmic sperm injection and other assisted reproductive technologies. Fellowship-trained reproductive endocrinologists Dr. Susan C. Conway, Dr. Carolyn Kaplan and Dr. Mark Perloe are experts in female and male disorders including polycystic ovary syndrome (PCOS), repeated pregnancy loss, menstrual disorders and azoospermia. GRS has three offices, Atlanta, Alpharetta and Decatur, to conveniently serve patients across Metro Atlanta. For more information about Georgia Reproductive Specialists, visit www.ivf.com.     Return to the IVF Homepage This page, and all contents, are Copyright © 2006 by IVF.com, Atlanta, GA, USA.